{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:49:27Z","timestamp":1782949767325,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Shanghai Key Clinical Specialty Construction Project-Tuberculosis Department","award":["shslczdzc03001"],"award-info":[{"award-number":["shslczdzc03001"]}]},{"name":"Study on optimization and effect evaluation of precise and short-term treatment plans for tuberculosis","award":["GWVI-11.1-05-01"],"award-info":[{"award-number":["GWVI-11.1-05-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04446-x","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:21:40Z","timestamp":1761808900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Key resistance-associated mutations in multidrug-resistant tuberculosis: a genomic study from Shanghai, China, with a focus on aminoglycosides"],"prefix":"10.1186","volume":"25","author":[{"given":"Yinjuan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"4446_CR1","unstructured":"Organization WH. Global tuberculosis report. 2024."},{"issue":"1","key":"4446_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-20273-7","volume":"24","author":"Q Li","year":"2024","unstructured":"Li Q, Wu Y, Cheng Q, Lu M, Huang Y, Bai X, et al. Prevalence and epidemic pattern of ecdemic multidrug-resistant tuberculosis during 2012\u20132022 in Hangzhou, China: implication for public health strategies. BMC Public Health. 2024;24(1):2859.","journal-title":"BMC Public Health"},{"issue":"1","key":"4446_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2302837","volume":"13","author":"M Li","year":"2024","unstructured":"Li M, Zhang Y, Wu Z, Jiang Y, Sun R, Yang J, et al. Transmission of fluoroquinolones resistance among multidrug-resistant tuberculosis in Shanghai, China: a retrospective population-based genomic epidemiology study. Emerg Microbes Infect. 2024;13(1):2302837.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"4446_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-024-00504-2","volume":"10","author":"K Dheda","year":"2024","unstructured":"Dheda K, Mirzayev F, Cirillo DM, Udwadia Z, Dooley KE, Chang KC, Omar SV, Reuter A, Perumal T, Horsburgh CR Jr., et al. Multidrug-resistant tuberculosis. Nat Rev Dis Primers. 2024;10(1):22.","journal-title":"Nat Rev Dis Primers."},{"key":"4446_CR5","first-page":"1","volume":"60","author":"OR Jones","year":"1948","unstructured":"Jones OR, Platt WD. Miliary tuberculosis caused by intravenous self-injection of tubercle bacilli, treated successfully with streptomycin therapy. Trans Am Clin Climatol Assoc. 1948;60:1\u201311.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"4446_CR6","first-page":"708","volume":"6","author":"M Shapiro","year":"1958","unstructured":"Shapiro M, Hyde L. Kanamycin in pulmonary tuberculosis. Antibiot Annu. 1958;6:708\u201310.","journal-title":"Antibiot Annu"},{"issue":"2","key":"4446_CR7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1128\/JCM.01476-09","volume":"48","author":"LE Via","year":"2010","unstructured":"Via LE, Cho SN, Hwang S, Bang H, Park SK, Kang HS, et al. Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from South Korean patients with drug-resistant tuberculosis. J Clin Microbiol. 2010;48(2):402\u201311.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"4446_CR8","first-page":"723","volume":"34","author":"M Barza","year":"1977","unstructured":"Barza M, Scheife RT. Drug therapy reviews: antimicrobial spectrum, pharmacology and therapeutic use of antibiotics\u2013part 4: aminoglycosides. Am J Hosp Pharm. 1977;34(7):723\u201337.","journal-title":"Am J Hosp Pharm"},{"issue":"6","key":"4446_CR9","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1365-2958.1993.tb01253.x","volume":"9","author":"M Finken","year":"1993","unstructured":"Finken M, Kirschner P, Meier A, Wrede A, Bottger EC. Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol Microbiol. 1993;9(6):1239\u201346.","journal-title":"Mol Microbiol"},{"issue":"2","key":"4446_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1128\/AAC.38.2.228","volume":"38","author":"A Meier","year":"1994","unstructured":"Meier A, Kirschner P, Bange FC, Vogel U, Bottger EC. Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance. Antimicrob Agents Chemother. 1994;38(2):228\u201333.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"4446_CR11","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.resmic.2004.06.007","volume":"155","author":"T Tracevska","year":"2004","unstructured":"Tracevska T, Jansone I, Nodieva A, Marga O, Skenders G, Baumanis V. Characterisation of rpsL, Rrs and embb mutations associated with streptomycin and ethambutol resistance in Mycobacterium tuberculosis. Res Microbiol. 2004;155(10):830\u20134.","journal-title":"Res Microbiol"},{"issue":"5","key":"4446_CR12","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1128\/AAC.42.5.1295","volume":"42","author":"GJ Alangaden","year":"1998","unstructured":"Alangaden GJ, Kreiswirth BN, Aouad A, Khetarpal M, Igno FR, Moghazeh SL, et al. Mechanism of resistance to Amikacin and Kanamycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1998;42(5):1295\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"4446_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033275","volume":"7","author":"SB Georghiou","year":"2012","unstructured":"Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, Rodwell TC. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PLoS ONE. 2012;7(3):e33275.","journal-title":"PLoS ONE"},{"issue":"4","key":"4446_CR14","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1128\/AAC.02191-12","volume":"57","author":"AZ Reeves","year":"2013","unstructured":"Reeves AZ, Campbell PJ, Sultana R, Malik S, Murray M, Plikaytis BB, et al. Aminoglycoside cross-resistance in Mycobacterium tuberculosis due to mutations in the 5\u2019 untranslated region of whiB7. Antimicrob Agents Chemother. 2013;57(4):1857\u201365.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"4446_CR15","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1128\/AAC.40.5.1186","volume":"40","author":"RC Cooksey","year":"1996","unstructured":"Cooksey RC, Morlock GP, McQueen A, Glickman SE, Crawford JT. Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in new York City. Antimicrob Agents Chemother. 1996;40(5):1186\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"4446_CR16","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1128\/AAC.01814-10","volume":"55","author":"SY Wong","year":"2011","unstructured":"Wong SY, Lee JS, Kwak HK, Via LE, Boshoff HI, Barry CE. 3rd: mutations in GidB confer low-level streptomycin resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2011;55(6):2515\u201322.","journal-title":"Antimicrob Agents Chemother"},{"key":"4446_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijid.2020.04.039","volume":"96","author":"X Wu","year":"2020","unstructured":"Wu X, Gao R, Shen X, Guo Y, Yang J, Wu Z, et al. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China. Int J Infect Dis. 2020;96:48\u201353.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"4446_CR18","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1016\/S2666-5247(21)00301-3","volume":"3","author":"TM Walker","year":"2022","unstructured":"Walker TM, Miotto P, Koser CU, Fowler PW, Knaggs J, Iqbal Z, Hunt M, Chindelevitch L, Farhat M, Cirillo DM, et al. The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: A genotypic analysis. Lancet Microbe. 2022;3(4):e265\u201373.","journal-title":"Lancet Microbe"},{"key":"4446_CR19","unstructured":"Catalogue of mutations in. Mycobacterium tuberculosis complex and their association with drug resistance, 2nd ed. 2023."},{"key":"4446_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-14-165","volume":"14","author":"A Sowajassatakul","year":"2014","unstructured":"Sowajassatakul A, Prammananan T, Chaiprasert A, Phunpruch S. Molecular characterization of amikacin, kanamycin and capreomycin resistance in M\/XDR-TB strains isolated in Thailand. BMC Microbiol. 2014;14:165.","journal-title":"BMC Microbiol"},{"issue":"1","key":"4446_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3009-9","volume":"18","author":"A Oudghiri","year":"2018","unstructured":"Oudghiri A, Karimi H, Chetioui F, Zakham F, Bourkadi JE, Elmessaoudi MD, et al. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis city in Morocco. BMC Infect Dis. 2018;18(1):98.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"4446_CR22","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cmi.2018.12.008","volume":"25","author":"MM Islam","year":"2019","unstructured":"Islam MM, Tan Y, Hameed HMA, Liu Z, Chhotaray C, Liu Y, Lu Z, Cai X, Tang Y, Gao Y, et al. Detection of novel mutations associated with independent resistance and cross-resistance to Isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates. Clin Microbiol Infect. 2019;25(8):1041. e1041-1041 e1047.","journal-title":"Clin Microbiol Infect"},{"key":"4446_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2147\/IDR.S152720","volume":"11","author":"S Osei-Wusu","year":"2018","unstructured":"Osei-Wusu S, Amo Omari M, Asante-Poku A, Darko Otchere I, Asare P, Forson A, et al. Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case. Infect Drug Resist. 2018;11:239\u201346.","journal-title":"Infect Drug Resist"},{"key":"4446_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jgar.2020.02.019","volume":"22","author":"MM Islam","year":"2020","unstructured":"Islam MM, Tan Y, Hameed HMA, Liu Y, Chhotaray C, Cai X, et al. Prevalence and molecular characterization of Amikacin resistance among Mycobacterium tuberculosis clinical isolates from Southern China. J Glob Antimicrob Resist. 2020;22:290\u20135.","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"4446_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-05947-6","volume":"21","author":"NF Sabur","year":"2021","unstructured":"Sabur NF, Brar MS, Wu L, Brode SK. Low-dose amikacin in the treatment of Multidrug-resistant tuberculosis (MDR-TB). BMC Infect Dis. 2021;21(1):254.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"4446_CR26","doi-asserted-by":"publisher","first-page":"e3929","DOI":"10.1093\/cid\/ciaa621","volume":"73","author":"JP Cegielski","year":"2021","unstructured":"Cegielski JP, Chan PC, Lan Z, Udwadia ZF, Viiklepp P, Yim JJ, et al. Aminoglycosides and capreomycin in the treatment of multidrug-resistant tuberculosis: individual patient data meta-analysis of 12 030 patients from 25 countries, 2009\u20132016. Clin Infect Dis. 2021;73(11):e3929-36.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"4446_CR27","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1128\/JCM.06860-11","volume":"50","author":"X Yuan","year":"2012","unstructured":"Yuan X, Zhang T, Kawakami K, Zhu J, Li H, Lei J, Tu S. Molecular characterization of multidrug- and extensively drug-resistant Mycobacterium tuberculosis strains in Jiangxi, China. J Clin Microbiol. 2012;50(7):2404\u201313.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"4446_CR28","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/jac\/dkp452","volume":"65","author":"J Perdigao","year":"2010","unstructured":"Perdigao J, Macedo R, Malaquias A, Ferreira A, Brum L, Portugal I. Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal. J Antimicrob Chemother. 2010;65(2):224\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"4446_CR29","doi-asserted-by":"crossref","unstructured":"Wei W, Zhao Y, Zhang C, Yu M, Wu Z, Xu L, Peng K, Wu Z, Li Y, Wang X. Whole-genome sequencing and transcriptome-characterized in vitro evolution of aminoglycoside resistance in Mycobacterium tuberculosis. Microb Genom. 2023;9(5).","DOI":"10.1099\/mgen.0.001022"},{"key":"4446_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12081324","author":"SM Jeon","year":"2023","unstructured":"Jeon SM, Park S, Lim NR, Lee N, Jung J, Sung N, et al. Molecular analysis of anti-Tuberculosis drug resistance of Mycobacterium tuberculosis isolated in the Republic of Korea. Antibiotics. 2023. https:\/\/doi.org\/10.3390\/antibiotics12081324.","journal-title":"Antibiotics"},{"issue":"11","key":"4446_CR31","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01164-21","volume":"65","author":"R Vargas Jr.","year":"2021","unstructured":"Vargas R Jr., Freschi L, Spitaleri A, Tahseen S, Barilar I, Niemann S, et al. Role of epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine resistance in Mycobacterium tuberculosis complex. Antimicrob Agents Chemother. 2021;65(11):e0116421.","journal-title":"Antimicrob Agents Chemother"},{"key":"4446_CR32","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00860-20","author":"KA Cohen","year":"2020","unstructured":"Cohen KA, Stott KE, Munsamy V, Manson AL, Earl AM, Pym AS. Evidence for expanding the role of streptomycin in the management of drug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2020. https:\/\/doi.org\/10.1128\/AAC.00860-20.","journal-title":"Antimicrob Agents Chemother"},{"key":"4446_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10101169","author":"P Bwalya","year":"2021","unstructured":"Bwalya P, Yamaguchi T, Solo ES, Chizimu JY, Mbulo G, Nakajima C, et al. Characterization of mutations associated with streptomycin resistance in Multidrug-Resistant Mycobacterium tuberculosis in Zambia. Antibiotics. 2021. https:\/\/doi.org\/10.3390\/antibiotics10101169.","journal-title":"Antibiotics"},{"issue":"2","key":"4446_CR34","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.diagmicrobio.2015.06.020","volume":"83","author":"LL Zhao","year":"2015","unstructured":"Zhao LL, Liu HC, Sun Q, Xiao TY, Zhao XQ, Li GL, et al. Identification of mutations conferring streptomycin resistance in multidrug-resistant tuberculosis of China. Diagn Microbiol Infect Dis. 2015;83(2):150\u20133.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"4446_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100078","volume":"9","author":"T Jagielski","year":"2014","unstructured":"Jagielski T, Ignatowska H, Bakula Z, Dziewit L, Napiorkowska A, Augustynowicz-Kopec E, et al. Screening for streptomycin resistance-conferring mutations in Mycobacterium tuberculosis clinical isolates from Poland. PLoS ONE. 2014;9(6):e100078.","journal-title":"PLoS ONE"},{"key":"4446_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jgar.2017.01.005","volume":"9","author":"AD Khosravi","year":"2017","unstructured":"Khosravi AD, Etemad N, Hashemzadeh M, Khandan Dezfuli S, Goodarzi H. Frequency of Rrs and RpsL mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from Iranian patients. J Glob Antimicrob Resist. 2017;9:51\u20136.","journal-title":"J Glob Antimicrob Resist"},{"issue":"11","key":"4446_CR37","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1093\/jac\/dkq322","volume":"65","author":"G Tudo","year":"2010","unstructured":"Tudo G, Rey E, Borrell S, Alcaide F, Codina G, Coll P, et al. Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis clinical isolates in the area of Barcelona. J Antimicrob Chemother. 2010;65(11):2341\u20136.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"4446_CR38","first-page":"858","volume":"94","author":"W Schwartz","year":"1966","unstructured":"Schwartz W. Capreomycin compared with streptomycin in original treatment of pulmonary tuberculosis. XVI. a report of the veterans Administration-Armed forces cooperative study on the chemotherapy of tuberculosis. Am Rev Respir Dis. 1966;94(6):858\u201364.","journal-title":"Am Rev Respir Dis"},{"key":"4446_CR39","unstructured":"WHO. Global tuberculosis report. 2022."},{"key":"4446_CR40","unstructured":"Use of targeted next-generation sequencing to detect drug-resistant tuberculosis. 2023."}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04446-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04446-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04446-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:21:46Z","timestamp":1761808906000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-04446-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4446"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04446-x","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Ethical Committee of Shanghai Pulmonary Hospital. Informed consent was obtained from all participants involved in the study. This research complied with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"702"}}